Factor VIII deficiency – Life with Disease

Go back

Factor VIII deficiency, commonly known as Hemophilia A, is an inherited bleeding disorder that affects how blood clots. Without enough of a crucial clotting protein called factor VIII, people with this condition may experience prolonged bleeding after injuries, surgeries, or even without apparent cause. Understanding how this condition progresses, what complications may arise, and how it impacts everyday living can help patients and their families better navigate life with hemophilia.

Prognosis and Life Expectancy

The outlook for people living with factor VIII deficiency has improved dramatically over the past few decades, thanks to advances in treatment and comprehensive care approaches. The prognosis depends largely on the severity of the condition, how early treatment begins, and whether the person develops certain complications such as inhibitors — antibodies that make treatment less effective.

People with severe hemophilia A typically face more frequent bleeding episodes and greater health challenges than those with mild or moderate forms. Severe hemophilia A is usually diagnosed within the first two years of life, often following bleeding from minor procedures or oral tissue injuries. Without preventive treatment, individuals with severe disease may experience two to five spontaneous bleeding episodes each month, including bleeding into joints or deep muscle tissue. These repeated bleeds can cause long-term joint damage if not properly managed.[2]

Those with moderate hemophilia A generally have less frequent spontaneous bleeding, though the pattern varies considerably between individuals. They typically experience prolonged or delayed bleeding after relatively minor injuries and are usually diagnosed before age five to six years. The frequency of bleeding episodes in this group ranges from once monthly to once yearly.[2]

Individuals with mild hemophilia A usually don’t have spontaneous bleeding episodes. Their condition often goes unnoticed until later in life, sometimes not being diagnosed until abnormal bleeding occurs during surgery or dental procedures. Even with mild disease, without proper pre- and post-operative treatment, significant bleeding can occur during medical procedures.[2]

Research has shown that people with hemophilia who receive care at specialized hemophilia treatment centers have significantly better long-term health outcomes. One study involving 3,000 boys and men found that those receiving care at these centers were 40 percent less likely to die from hemophilia-related complications compared to those not receiving specialized care.[22]

About 10 percent of patients with factor VIII deficiency do not present with bleeding symptoms, though they still carry the diagnosis based on laboratory findings. This highlights why a prolonged activated partial thromboplastin time should never be ignored before invasive procedures, even in someone without a bleeding history.[15]

⚠️ Important
Factor VIII activity levels at the time of diagnosis, the presence and strength of inhibitors, and the type of autoantibodies present are all prognostic markers for both remission of acute bleeding episodes and long-term survival. Knowing these factors can help healthcare providers tailor treatment plans and set realistic expectations for disease management.

Natural Progression Without Treatment

When factor VIII deficiency goes untreated or is inadequately managed, the disease follows a progressive course that can significantly impact physical health and quality of life. The natural history of untreated hemophilia A centers around repeated bleeding episodes that accumulate damage over time, particularly to the musculoskeletal system.

The most characteristic feature of untreated hemophilia A is bleeding into the joints, a condition called hemarthrosis. Without treatment, people with severe hemophilia may experience spontaneous joint bleeds that occur without any obvious injury. The knees, elbows, and ankles are most commonly affected. When blood enters a joint space, it causes immediate swelling, pain, warmth, and stiffness. The joint may feel tight and movement becomes limited.[3][5]

Over time, repeated bleeding into the same joint creates what clinicians call a “target joint.” Each bleeding episode damages the delicate cartilage and synovial membrane lining the joint. The blood itself is toxic to joint tissues, triggering inflammation and eventually leading to a cycle where the damaged joint becomes even more prone to bleeding. This creates a self-perpetuating problem where bleeds become more frequent in already damaged joints.[12]

As years pass without adequate treatment, chronic joint disease develops. The repeated insults to the joint cause permanent changes including cartilage destruction, bone erosion, and eventually severe arthritis. The joint may become deformed, with visible changes in shape and alignment. Range of motion becomes increasingly restricted, and chronic pain becomes a constant companion. In severe cases, the joint may become completely immobile and require surgical intervention such as joint replacement.[4]

Bleeding can also occur in muscles, particularly in large muscle groups such as the thigh or calf muscles. Deep muscle bleeds create large, painful swellings called hematomas. These collections of blood can compress nearby nerves and blood vessels, potentially causing numbness, tingling, or even tissue death if left untreated. Unlike joint bleeds, muscle hematomas may take weeks to resolve completely and can leave behind scarring and weakness.[3]

Bleeding in soft tissues creates visible bruising that may appear disproportionate to the degree of trauma. These bruises can be large, painful, and slow to heal. They represent blood that has leaked into the tissue spaces where it doesn’t belong, and the body must slowly break down and reabsorb this blood over time.[5]

Perhaps most concerning is that untreated hemophilia A increases the risk of bleeding in critical locations. While less common than joint or muscle bleeds, bleeding into the brain, throat, or abdominal organs can be life-threatening and requires immediate medical attention. Even seemingly minor head injuries can lead to dangerous intracranial bleeding in someone with untreated severe hemophilia.[3]

The pattern of disease progression means that early intervention makes a tremendous difference. Studies have consistently shown that preventive therapy started early in childhood can reduce total bleeds and bleeding into joints, resulting in decreased overall joint deterioration and improved quality of life compared to treating bleeds only as they occur.[4]

Possible Complications

Beyond the expected bleeding episodes, factor VIII deficiency can lead to several unexpected and serious complications that affect both physical health and overall well-being. Understanding these potential problems helps patients and families recognize warning signs and seek timely medical care.

One of the most significant complications is the development of inhibitors. These are antibodies produced by the immune system that attack and neutralize factor VIII, whether it’s the body’s own factor VIII or replacement factor given as treatment. Inhibitors make bleeding much harder to control because standard treatments become ineffective. Some people with inhibitors require specialized treatments using bypassing agents or other approaches to stop bleeding. The presence of inhibitors substantially complicates disease management and increases the risk of serious bleeding complications.[3][10]

Bleeding into the brain represents one of the most feared complications of hemophilia A. Intracranial hemorrhage can occur spontaneously or following even minor head trauma. Symptoms may include severe headache that doesn’t respond to usual pain relievers, double vision, confusion, weakness on one side of the body, or changes in consciousness. This is a medical emergency requiring immediate treatment, as bleeding inside the skull can rapidly become life-threatening due to increased pressure on brain tissue.[5]

Chronic pain becomes a significant issue for many people with hemophilia A, particularly those who have experienced repeated joint bleeds. The pain may be constant or may flare with activity. It can be severe enough to interfere with sleep, work, and daily activities. Managing chronic pain in hemophilia requires a careful balance, as many pain medications, particularly non-steroidal anti-inflammatory drugs like aspirin and ibuprofen, can interfere with blood clotting and increase bleeding risk.[5][22]

Mental health complications, including anxiety and depression, are common among people living with hemophilia A. The unpredictability of bleeding episodes, chronic pain, physical limitations, and the burden of managing a lifelong condition all contribute to emotional distress. Fear of bleeding may cause some individuals to become overly cautious, limiting their activities more than medically necessary. Others may experience depression related to chronic pain, disability, or feeling different from peers.[5]

Cardiovascular complications may develop over time. Research suggests that people with hemophilia A may have an increased risk of heart disease compared to the general population. The reasons for this are complex and may relate to reduced physical activity due to joint problems, treatment-related factors, or other aspects of living with a chronic condition.[5]

Gastrointestinal and urinary tract bleeding, while less common than joint or muscle bleeds, can occur and may be difficult to diagnose initially. Blood in the urine or stool should always prompt medical evaluation. These types of internal bleeding may not cause immediate pain but can lead to significant blood loss and anemia if not recognized and treated.[3]

Dental procedures pose particular challenges for people with hemophilia A. Even routine tooth extractions can lead to prolonged bleeding. The mouth has many blood vessels, and the moist environment makes it difficult for clots to form and remain stable. Proper planning with both the dentist and hematology team is essential before any dental work.[3]

Anemia, or low red blood cell count, may develop in people who experience frequent or large bleeds. Each bleeding episode results in blood loss, and with it, loss of iron and other nutrients needed to make red blood cells. Maintaining adequate iron levels is particularly important, as an estimated 0.75 micrograms of iron is lost with each 15 milliliters of blood lost.[19]

Impact on Daily Life

Living with factor VIII deficiency affects virtually every aspect of daily life, from physical activities to emotional well-being, social relationships, and career choices. The extent of impact varies depending on disease severity, but even mild hemophilia can create challenges that require thoughtful management and adaptation.

Physical activity represents one of the most complex areas for people with hemophilia. On one hand, regular exercise is crucial for maintaining muscle strength and joint health, which can actually reduce the risk of bleeding episodes. Stronger muscles provide better support and protection for joints. On the other hand, certain high-impact or contact activities carry increased risk of injury and bleeding. This creates a delicate balance where staying active is important, but choosing appropriate activities requires careful consideration.[22]

Factor VIII activity levels directly influence what activities a person can safely pursue. Those with normal or near-normal factor levels (above 40-50 percent) may engage in higher-impact activities such as sports and physically demanding jobs with relatively low risk. People with mild hemophilia (5 to less than 40 percent factor activity) can often participate in moderate activities like aerobics, cycling, swimming, or Pilates, though some pain or discomfort may occur. Those with more severe disease often need to be more selective about activities to minimize bleeding risk.[6]

Many people with hemophilia, particularly those diagnosed from childhood, report making lifestyle adjustments to reduce bleeding risk. This might mean avoiding contact sports, choosing desk jobs over physically demanding careers, or being extra cautious in situations where injury is possible. Some individuals become less physically active than they would prefer, partly due to legitimate medical concerns but sometimes also due to excessive caution born from fear of bleeding.[17][18]

The unpredictability of bleeding episodes creates its own burden. Spontaneous bleeds can occur without warning, potentially disrupting plans, requiring urgent treatment, and causing pain that interferes with work, school, or social activities. This unpredictability may lead to anxiety about traveling, making commitments, or participating in activities far from medical care.[17]

Managing hemophilia requires significant time and effort. Many people with hemophilia learn to give themselves intravenous infusions of factor replacement at home. While this allows for prompt treatment of bleeds and can prevent complications, it also means incorporating medical procedures into regular routines. Some people receive preventive infusions several times per week, which requires planning and time. Keeping an emergency kit with necessary supplies ready at all times becomes part of daily life.[17][22]

Diet and nutrition play supportive roles in managing hemophilia. Maintaining a healthy weight is particularly important because excess weight puts additional stress on joints, potentially increasing bleeding risk. Iron-rich foods help maintain healthy red blood cell levels, especially important for those who experience frequent bleeding. Some dietary supplements may need to be avoided because they can interfere with clotting, including vitamin E, fish oil, ginkgo biloba, and certain other natural products. Discussing any supplements with healthcare providers before taking them is essential.[19][21]

Social and emotional impacts can be substantial. Children with hemophilia may feel different from peers, particularly if they cannot participate in popular sports or activities. Adults may face challenges in dating relationships when explaining their condition. The visible bruising characteristic of hemophilia can prompt unwanted questions or concerns from others who don’t understand the condition.[17]

Career choices may be influenced by hemophilia. Jobs requiring heavy physical labor, working at heights, or operating dangerous machinery may pose unacceptable risks. Conversely, jobs that are too sedentary may not provide enough physical activity to maintain optimal joint and muscle health. Finding the right balance requires considering individual disease severity, treatment regimen, and personal interests.[20]

Financial concerns add another layer of stress. Treatment for hemophilia can be extremely expensive. Factor replacement products are among the most costly medications available. Even with insurance, co-payments and out-of-pocket costs can create financial hardship. Some people delay or skip treatments due to cost concerns, which can lead to worse health outcomes.[4]

Despite these challenges, many people with hemophilia lead full, active, and satisfying lives. Connecting with others who have the condition through support groups or hemophilia organizations can reduce feelings of isolation and provide practical advice. Modern treatments have dramatically improved outcomes, and ongoing research continues to develop new therapies that may eventually lead to a cure.[17][22]

⚠️ Important
Establishing daily routines that include taking medications on time, following a balanced diet, staying properly hydrated, and engaging in safe physical activities can help prevent complications and improve overall quality of life. Daily management isn’t just about avoiding crises—it’s about creating a lifestyle that supports long-term health and allows participation in desired activities with fewer limitations.

Support for Family Members

Family members play a crucial role in supporting someone with factor VIII deficiency, and their involvement can significantly impact health outcomes and quality of life. Understanding how to help, what to watch for, and how to navigate the healthcare system together strengthens the entire family’s ability to cope with this lifelong condition.

For parents of children with hemophilia, the diagnosis often comes as a shock, particularly in families with no previous history of bleeding disorders. About 30 percent of cases result from spontaneous genetic mutations rather than inheritance, meaning many families have no warning or prior knowledge about hemophilia when their child is diagnosed. Learning about the condition, understanding treatment options, and connecting with resources becomes the first priority for these families.[9]

Education is fundamental for family support. Parents, partners, and other family members should learn to recognize signs of bleeding, understand when to seek medical care, and know how to provide first aid for common bleeding situations. Many comprehensive hemophilia treatment centers offer education programs for families, teaching them about the disease, its management, and practical caregiving skills. Some family members learn to administer factor replacement infusions at home, which allows for faster treatment of bleeding episodes.[10][22]

Creating a supportive home environment matters tremendously. For children with hemophilia, this means balancing protection with allowing normal childhood experiences. Overprotecting a child can lead to anxiety, reduced physical fitness, and social isolation, while being too permissive may result in injuries and bleeding. Finding the right balance involves working closely with the healthcare team to understand what activities are appropriate and how to make them as safe as possible. It also means focusing on the whole child, not just the diagnosis.[17]

When it comes to clinical trials, family members can help in several important ways. Clinical trials represent opportunities to access cutting-edge treatments and contribute to research that may benefit future generations of people with hemophilia. However, deciding whether to participate in a trial requires careful consideration of potential benefits and risks. Family members can help by researching available trials, attending appointments where trial information is discussed, asking questions about study protocols and potential side effects, and providing emotional support during the decision-making process.[4]

Preparing for clinical trial participation involves several steps where family support is valuable. This includes organizing medical records, understanding the current treatment regimen and how it compares to what the trial offers, keeping track of bleeding episodes and their frequency, and ensuring transportation to and from trial appointments. Some trials require frequent visits or monitoring, which may be challenging to manage without family support.[4]

Family members should understand that clinical trials have different phases, each with specific purposes. Early-phase trials typically test safety and determine appropriate dosing. Later-phase trials compare new treatments to existing ones to see if they work better or have fewer side effects. Knowing what phase a trial is in helps families understand what to expect and what questions to ask.[4]

Emotional support from family cannot be overstated. Living with a chronic bleeding disorder can be frightening, frustrating, and exhausting. Having family members who listen without judgment, validate feelings, and provide encouragement makes a significant difference in coping ability. Family members should watch for signs of depression or anxiety in their loved one with hemophilia and encourage professional mental health support when needed.[17]

Practical assistance helps reduce the burden of disease management. This might include helping to organize medications, setting reminders for infusions or appointments, preparing nutritious meals, assisting with household tasks during bleeding episodes when movement is limited, and helping to maintain a bleeding diary that tracks episodes and treatment responses. These seemingly small acts of support can significantly reduce the stress of managing hemophilia.[18]

Family members can serve as advocates in healthcare settings. This means attending medical appointments, asking questions, ensuring clear communication between the patient and healthcare providers, and helping to coordinate care among different specialists. In emergencies, family members who understand the condition can provide crucial information to emergency personnel who may not be familiar with hemophilia.[22]

Connecting with other families affected by hemophilia provides valuable peer support. Local chapters of hemophilia organizations often host family events, support groups, and educational programs. These connections allow families to share experiences, learn from others who have faced similar challenges, and build friendships with people who truly understand what living with hemophilia entails. Many organizations also offer camps for children with bleeding disorders, giving them opportunities to meet peers and participate in activities in a medically supervised environment.[17]

Financial advocacy represents another way families can help. This includes understanding insurance coverage, appealing denied claims, researching patient assistance programs, and connecting with resources that help cover treatment costs. Comprehensive hemophilia treatment centers often have social workers who can guide families through these processes.[4]

For families considering genetic testing or family planning, understanding inheritance patterns is important. Hemophilia A follows an X-linked recessive inheritance pattern, primarily affecting males. Women who carry the gene have a 50 percent chance of passing it to each child. Male children who inherit the gene will have hemophilia, while female children who inherit it become carriers. Understanding these patterns helps families make informed decisions about genetic counseling and testing.[3][9]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Recombinant Factor VIII Concentrates – Genetically engineered clotting factor products that do not contain human plasma and are used for replacement therapy in hemophilia A
  • Plasma-Derived Factor VIII Concentrates – Clotting factor replacement products made from human plasma proteins, treated to remove or inactivate bloodborne viruses
  • Desmopressin (DDAVP) – A medication that stimulates the body to release stored factor VIII, used primarily for mild hemophilia A
  • Emicizumab (Hemlibra) – A non-factor product given by injection under the skin that helps prevent bleeding episodes in hemophilia A
  • Recombinant Activated Factor VII – A bypassing agent used to treat bleeding in patients with inhibitors
  • Activated Prothrombin Complex Concentrate – A bypassing agent used to control bleeding episodes in patients with inhibitors
  • Recombinant Porcine Factor VIII – An alternative factor replacement product used for bleeding treatment
  • Anti-fibrinolytic Medications – Clot-preserving medications that help prevent the breakdown of blood clots

Ongoing Clinical Trials on Factor VIII deficiency

  • Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

    Recruiting

    1 1 1
    Investigated drugs:
    Bulgaria France Greece Italy Lithuania Norway +4
  • Study on Synovial Hypertrophy in Patients with Hemophilia A Using Efanesoctocog Alfa Prophylaxis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Norway Spain Sweden

References

https://www.bleeding.org/bleeding-disorders-a-z/types/hemophilia-a

https://www.ncbi.nlm.nih.gov/gtr/conditions/C0019069/

https://medlineplus.gov/ency/article/000538.htm

https://emedicine.medscape.com/article/779322-treatment

https://my.clevelandclinic.org/health/diseases/23197-hemophilia-a

https://www.altuviiio.com/hemophilia-education/factor-activity-levels

https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=167&contentid=factor_viii

https://kidshealth.org/CHOC/en/parents/az-factor-viii.html

https://www.bleedingdisorders.com/hemophilia-a

https://www.cdc.gov/hemophilia/treatment/index.html

https://emedicine.medscape.com/article/779322-treatment

https://www.ncbi.nlm.nih.gov/books/NBK470265/

https://www.mayoclinic.org/diseases-conditions/hemophilia/diagnosis-treatment/drc-20373333

https://my.clevelandclinic.org/health/diseases/23197-hemophilia-a

https://haematologica.org/article/view/9931

https://www.bleeding.org/healthcare-professionals/guidelines-on-care/products-licensed-in-the-us

https://www.myhemophiliateam.com/resources/tips-for-living-well-with-hemophilia

https://hemophiliaoutreach.org/coping-with-bleeding-disorders-practical-lifestyle-tips-for-daily-management/

https://www.bjh.be/haemophilia-five-things-to-eat-and-five-things-to-avoid/

https://www.rareblooddisorders.com/patient/resources/hemophilia/all-about-hemophilia/hemophilia-education-101

https://factormyway.com/home/bleeding-disorder-resources.html

https://www.everydayhealth.com/hemophilia/living-well-with-hemophilia-preventive-care-first-aid-lifestyle/

https://www.cdc.gov/hemophilia/treatment/index.html

FAQ

Can women have hemophilia A or are they just carriers?

While hemophilia A primarily affects males, women can experience symptoms too. About 30% of female carriers have factor VIII levels below 40% and are at risk for bleeding, including heavy menstrual periods and excessive bleeding after injuries or surgery. Some women may have more significant symptoms even if males in their family are only mildly affected.

What is the difference between severe, moderate, and mild hemophilia A?

The classification depends on factor VIII activity levels. Severe hemophilia A (less than 1% factor activity) causes frequent spontaneous bleeding episodes. Moderate hemophilia A (1-5% factor activity) results in occasional spontaneous bleeding with variable frequency. Mild hemophilia A (5% to less than 40% activity) typically doesn’t cause spontaneous bleeding but leads to excessive bleeding after injuries, surgery, or dental procedures.

What are inhibitors and why are they a serious complication?

Inhibitors are antibodies that the immune system produces against factor VIII, whether it’s the body’s own factor or replacement factor given as treatment. They essentially neutralize the clotting factor, making it ineffective. This makes bleeding much harder to control because standard factor replacement therapy doesn’t work, requiring specialized bypassing agents or other alternative treatments.

Should people with hemophilia A avoid all physical activity?

No, regular physical activity is actually important for people with hemophilia A. Exercise helps maintain muscle strength and joint health, which can reduce bleeding risk. However, activity choices should be appropriate for disease severity. Low-impact activities like swimming, cycling, and walking are generally safer, while high-contact sports may pose greater risks. Discussing activity plans with your healthcare team helps find the right balance.

Why is care at a hemophilia treatment center important?

Hemophilia treatment centers provide specialized, comprehensive care from teams that include hematologists, orthopedists, nurses, physical therapists, and social workers who understand bleeding disorders. Research shows people receiving care at these centers have better long-term health outcomes and are 40% less likely to die from hemophilia-related complications compared to those receiving care elsewhere.

🎯 Key takeaways

  • Factor VIII deficiency severity directly correlates with bleeding frequency—severe cases may have 2-5 spontaneous bleeds monthly while mild cases rarely bleed without injury
  • Repeated joint bleeds create “target joints” that become increasingly prone to bleeding, eventually leading to chronic arthritis and deformity without proper treatment
  • People receiving care at specialized hemophilia treatment centers have 40% lower mortality from disease complications compared to those receiving care elsewhere
  • Early preventive therapy in childhood significantly reduces total bleeding episodes and joint damage compared to treating bleeds only as they occur
  • Factor VIII activity levels determine lifestyle limitations—those with near-normal levels can engage in high-impact activities while severe cases require more caution
  • Inhibitors develop in some patients, making treatment ineffective and requiring specialized bypassing agents to control bleeding
  • About 30% of hemophilia A cases occur from spontaneous mutations without any family history, surprising families at diagnosis
  • Female carriers can experience bleeding symptoms—approximately 30% have low enough factor VIII levels to cause increased bleeding tendency